A phase 2, multicenter, open-label study of sepantronium...

Cancer Medicine 2015 / 05 Vol. 4; Iss. 5

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G., Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Language:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.363
Date:
May, 2015
File:
PDF, 644 KB
english, 2015
Conversion to is in progress
Conversion to is failed